(MT Newswires) -- Dutch Philips Group (PHG) CEO Roy Jakobs discusses the consequences of the sleep apnea machine recall. The Dutch medical equipment manufacturer has not given a definitive figure for the cost of the recall, as the legal proceedings are not over, but claims that 99% of defective devices have been replaced. While the company has recorded three consecutive quarters of growth, it points to investments in artificial intelligence, estimated at over a billion euros a year.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
24.2 EUR | +2.98% | -2.41% | +15.80% |
May. 07 | PHILIPS : Jefferies remains negative, but raises its target | CF |
May. 07 | PHILIPS NV : Jefferies remains a Sell rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.80% | 23.66B | |
+8.07% | 219B | |
+7.87% | 185B | |
+12.75% | 135B | |
-1.37% | 62.21B | |
+4.88% | 51.01B | |
+11.59% | 51.28B | |
+2.71% | 41.85B | |
+4.90% | 37.02B | |
+23.75% | 31.27B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO